These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 17565646)

  • 1. Predictors for squamous re-epithelialization of Barrett's esophagus after endoscopic biopsy.
    Amano Y; Kushiyama Y; Yuki T; Takahashi Y; Chinuki D; Ishimura N; Furuta K; Ishihara S; Adachi K; Maruyama R; Kinoshita Y
    J Gastroenterol Hepatol; 2007 Jun; 22(6):901-7. PubMed ID: 17565646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REG Ialpha protein expression in Barrett's esophagus.
    Chinuki D; Amano Y; Ishihara S; Moriyama N; Ishimura N; Kazumori H; Kadowaki Y; Takasawa S; Okamoto H; Kinoshita Y
    J Gastroenterol Hepatol; 2008 Feb; 23(2):296-302. PubMed ID: 18289358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype.
    Amano Y; Kushiyama Y; Yuki T; Takahashi Y; Moriyama I; Fukuhara H; Ishimura N; Furuta K; Ishihara S; Adachi K; Maruyama R; Kinoshita Y
    Scand J Gastroenterol; 2006 Aug; 41(8):873-9. PubMed ID: 16803684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the clinical significance of stromal angiogenesis in Barrett's esophagus?
    Moriyama N; Amano Y; Mishima Y; Okita K; Takahashi Y; Yuki T; Ishimura N; Ishihara S; Kinoshita Y
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S210-5. PubMed ID: 19120900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's oesophagus with predominant intestinal metaplasia correlates with superficial cyclo-oxygenase-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by non-steroidal anti-inflammatory drugs usage.
    Amano Y; Ishihara S; Kushiyama Y; Yuki T; Takahashi Y; Chinuki D; Miyake T; Miyaoka Y; Rumi MA; Ishimura N; Adachi K; Kinoshita Y
    Aliment Pharmacol Ther; 2004 Oct; 20(7):793-802. PubMed ID: 15379840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression.
    Kahaleh M; Van Laethem JL; Nagy N; Cremer M; Devière J
    Endoscopy; 2002 Dec; 34(12):950-5. PubMed ID: 12471537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3420-6. PubMed ID: 10606297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of recurrent specialized intestinal metaplasia after complete laser ablation.
    Fisher RS; Bromer MQ; Thomas RM; Cohen S; Krevsky B; Horwitz B; Glazier KD; Das K; Das KM
    Am J Gastroenterol; 2003 Sep; 98(9):1945-51. PubMed ID: 14499770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
    Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
    Sharma P; Sampliner RE; Camargo E
    Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy.
    El-Serag HB; Aguirre T; Kuebeler M; Sampliner RE
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1255-60. PubMed ID: 15191506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous islands in Barrett's esophagus: what lies underneath?
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1998 Mar; 93(3):332-5. PubMed ID: 9517634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy for Barrett's esophagus: clinical update.
    Overholt BF; Panjehpour M
    Am J Gastroenterol; 1996 Sep; 91(9):1719-23. PubMed ID: 8792687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High power setting argon plasma coagulation for the eradication of Barrett's esophagus.
    Pereira-Lima JC; Busnello JV; Saul C; Toneloto EB; Lopes CV; Rynkowski CB; Blaya C
    Am J Gastroenterol; 2000 Jul; 95(7):1661-8. PubMed ID: 10925965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy.
    Eloubeidi MA; Provenzale D
    Am J Gastroenterol; 1999 Apr; 94(4):937-43. PubMed ID: 10201460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal squamous carcinoma in five patients with Barrett's esophagus.
    Paraf F; Fléjou JF; Potet F; Molas G; Fékété F
    Am J Gastroenterol; 1992 Jun; 87(6):746-50. PubMed ID: 1590313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis.
    Weston AP; Sharma P; Mathur S; Banerjee S; Jafri AK; Cherian R; McGregor D; Hassanein RS; Hall M
    Am J Gastroenterol; 2004 Sep; 99(9):1657-66. PubMed ID: 15330898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.